HoChong's Shared Resources

SVR Drives Long-Term Symptom Relief and Health Gains in Real-World HCV Study
In a large, real-world study of 1,601 patients treated for hepatitis C across 11 US medical centers, those who achieved...

Expanding Hepatitis C Virus Care for People Who Inject Drugs
Injection drug use (IDU) is the primary driver of hepatitis C virus (HCV) infection in North America and Europe, with...

Closing the Gaps in Hepatitis C Care: Screening, Treatment, and the Path to Elimination
Despite the availability of effective direct-acting antivirals and global goals to eliminate the hepatitis C virus (HCV) by 2030, only...